IP Library Granted Patent US 7,544,497
Granted Patent B2
US 7,544,497 · App. 10/884,879 · Granted Jun 9, 2009

Compositions for manipulating the lifespan and stress response of cells and organisms

Assignees: President and Fellows of Harvard College; Biomol International LP
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,544,497
App. No.
10/884,879
Granted
Jun 9, 2009
Kind
B2
Abstract

Provided herein are methods and compositions for modulating the activity of sirtuin deacetylase protein family members; p53 activity; apoptosis; lifespan and sensitivity to stress of cells and organisms. Exemplary methods comprise contacting a cell with an activating compound, such as a flavone, stilbene, flavanone, isoflavone, catechin, chalcone, tannin or anthocyanidin; or an inhibitory compound, such as a sphingolipid, e.g., sphingosine.

Claims (12)

1. A method for increasing the deacetylase activity of SIRT1in a eukaryotic cell, comprising contacting a eukaryotic cell with a non-naturally occurring agent that binds SIRT1, reduces the K m of SIRT1 for substrate and thereby increases the deacetylase activity of SIRT1.

2. The method of claim 1 , wherein the agent is an organic molecule.

3. The method of claim 1 , wherein the agent is an isolated agent.

4. The method of claim 1 , wherein the agent does not have significant anti-oxidant activities.

5. The method of claim 1 , wherein the agent reduces the K m of SIRT1 for substrate by a factor of at least about 30.

6. The method of claim 1 , wherein the agent reduces the K m of SIRT1 for NAD + by a factor of at least about 3.

7. The method of claim 1 , wherein the agent activates the deacetylase activity of SIRT1 by a factor of at least about 10.

8. The method of claim 1 , wherein the agent causes at least a 10% greater induction of the deacetylase activity of SIRT1 relative to that caused by the same concentration of resveratrol.

9. The method of claim 1 , wherein the eukaryotic cell is a mammalian cell.

10. The method of claim 9 , wherein the mammalian cell is a human cell.

11. The method of claim 1 further comprising contacting the eukaryotic cell with a second agent that binds SIRT1, reduces the K m of SIRT1 for substrate and thereby increases the deacetylase activity of SIRT1.

12. The method of claim 1 , further comprising contacting the eukaryotic cell with another agent that binds another sirtuin, reduces the K m of the other sirtuin for substrate and thereby increases the deacetylase activity of the other sirtuin.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2008
From: BIOMOL INTERNATIONAL, L.P.
To: BIOMOL INTERNATIONAL, INC.
Reel/Frame 020952/0695 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2006
From: BITTERMAN, KEVIN J.; LAMMING, DUDLEY W.
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 018352/0532 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2005
From: HOWITZ, KONRAD T.; ZIPKIN, ROBERT E.
To: BIOMOL INTERNATIONAL LP
Reel/Frame 015669/0435 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2005
From: SINCLAIR, DAVID A.
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 015669/0509 →
Continuity (3)
Provisional Application 6048394900 · Jul 1, 2003
Provisional Application 6053215800 · Dec 23, 2003
Related Publication 20050136537A1 · Jun 23, 2005